Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1/2 3Phase 1 3Phase NA 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Leukemia 11Multiple Myeloma 10Lymphoma 10Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Acute 8Congenital Abnormalities 8Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Leukemia, Myeloid, Accelerated Phase 7Burkitt Lymphoma 7Neoplasms, Plasma Cell 6Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Recurrence 5Primary Myelofibrosis 5Lymphoma, T-Cell, Cutaneous 5Leukemia, Myelomonocytic, Chronic 5Dendritic Cell Sarcoma, Interdigitating 5Blast Crisis 5Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Leukemia, Myelomonocytic, Juvenile 4

Interventions

fludarabine 5Cyclophosphamide 5Cyclosporine 4fludarabine phosphate 3Whole-Body Irradiation 3Imatinib Mesylate 3Therapeutics 2Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Methotrexate 2Hematologic Tests 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1nilotinib 1bosutinib 1Urinalysis 1Transplantation, Homologous 1Tetanus Toxoid 1Standard of Care 1Resistance Training 1Registries 1Radiotherapy 1Pharmaceutical Services 1Ondansetron 1Nurse Clinicians 1Modafinil 1Melphalan 1Health Promotion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Antilymphocyte Serum × Clear all
NCT00176930 2021-01-22

Stem Cell Transplant for Hematological Malignancy

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
330 enrolled 25 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02487069 2020-03-05

Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy

Nanfang Hospital, Southern Medical University

Phase NA Completed
876 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡